These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33011242)

  • 21. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?
    Nijs J; Meeus M; Versijpt J; Moens M; Bos I; Knaepen K; Meeusen R
    Expert Opin Ther Targets; 2015 Apr; 19(4):565-76. PubMed ID: 25519921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
    Ogata Y; Nemoto W; Yamagata R; Nakagawasai O; Shimoyama S; Furukawa T; Ueno S; Tan-No K
    Eur J Pain; 2019 Apr; 23(4):739-749. PubMed ID: 30421564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-derived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat.
    Zhou LJ; Yang T; Wei X; Liu Y; Xin WJ; Chen Y; Pang RP; Zang Y; Li YY; Liu XG
    Brain Behav Immun; 2011 Feb; 25(2):322-34. PubMed ID: 20933591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib-Induced Neuropathic Pain.
    Guo Y; Xu X; Huang J; Wang Z; Li Z; Liu Z
    Biomed Res Int; 2020; 2020():8143754. PubMed ID: 32733956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
    Robinson AJ; Dickenson JM
    Eur J Pharmacol; 2001 Feb; 413(2-3):151-61. PubMed ID: 11226388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of the hippocampal glutamate, GABA and the BDNF levels associated with spatial memory performance in a rodent model of neuropathic pain.
    Saffarpour S; Shaabani M; Naghdi N; Farahmandfar M; Janzadeh A; Nasirinezhad F
    Physiol Behav; 2017 Jun; 175():97-103. PubMed ID: 28336100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulators of G protein signalling as pharmacological targets for the treatment of neuropathic pain.
    Doyen PJ; Beckers P; Brook GA; Hermans E
    Pharmacol Res; 2020 Oct; 160():105148. PubMed ID: 32858121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The known knowns of microglia-neuronal signalling in neuropathic pain.
    Beggs S; Salter MW
    Neurosci Lett; 2013 Dec; 557 Pt A():37-42. PubMed ID: 23994389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of BDNF/TrkB signalling in the rACC to the development of pain-related aversion via activation of ERK in rats with spared nerve injury.
    Wang X; Zhang L; Zhan Y; Li D; Zhang Y; Wang G; Zhang M
    Brain Res; 2017 Sep; 1671():111-120. PubMed ID: 28732667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the SIM-A9 cell line as a model of activated microglia in the context of neuropathic pain.
    Dave KM; Ali L; Manickam DS
    PLoS One; 2020; 15(4):e0231597. PubMed ID: 32287325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats.
    Obata K; Yamanaka H; Dai Y; Mizushima T; Fukuoka T; Tokunaga A; Noguchi K
    Eur J Neurosci; 2004 Dec; 20(11):2881-95. PubMed ID: 15579142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38.
    Schulte G; Fredholm BB
    Exp Cell Res; 2003 Oct; 290(1):168-76. PubMed ID: 14516797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pain-relieving prospects for adenosine receptors and ectonucleotidases.
    Zylka MJ
    Trends Mol Med; 2011 Apr; 17(4):188-96. PubMed ID: 21236731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a novel analgesic for neuropathic pain targeting brain-derived neurotrophic factor.
    Ikeda K; Hazama K; Itano Y; Ouchida M; Nakatsuka H
    Biochem Biophys Res Commun; 2020 Oct; 531(3):390-395. PubMed ID: 32800540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-derived neurotrophic factor redistribution in the dorsal root ganglia correlates with neuropathic pain inhibition after resiniferatoxin treatment.
    Tender GC; Li YY; Cui JG
    Spine J; 2010 Aug; 10(8):715-20. PubMed ID: 20452292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of neural cell adhesion molecule signaling in glial cell line-derived neurotrophic factor-induced analgesia in a rat model of neuropathic pain.
    Sakai A; Asada M; Seno N; Suzuki H
    Pain; 2008 Jul; 137(2):378-388. PubMed ID: 17967506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine receptor targets for pain.
    Sawynok J
    Neuroscience; 2016 Dec; 338():1-18. PubMed ID: 26500181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1.
    Xia L; Zhang Y; Dong T
    J Mol Neurosci; 2016 Jul; 59(3):411-20. PubMed ID: 27059231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amitriptyline inhibits the MAPK/ERK and CREB pathways and proinflammatory cytokines through A3AR activation in rat neuropathic pain models.
    Kim Y; Kwon SY; Jung HS; Park YJ; Kim YS; In JH; Choi JW; Kim JA; Joo JD
    Korean J Anesthesiol; 2019 Feb; 72(1):60-67. PubMed ID: 29969887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excitatory actions of GABA increase BDNF expression via a MAPK-CREB-dependent mechanism--a positive feedback circuit in developing neurons.
    Obrietan K; Gao XB; Van Den Pol AN
    J Neurophysiol; 2002 Aug; 88(2):1005-15. PubMed ID: 12163549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.